Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1085268

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1085268

Regenerative Therapies Market, By Tissue Type, By Application, By End User, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

PUBLISHED:
PAGES: 171 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4500
PDF (Multi User License)
USD 7000
PDF (Enterprise User License)
USD 10000

Add to Cart

Regenerative medicine is one the fastest emerging fields of medicine, as it adopts stem cells for treatment. Increasing age or injury, makes it difficult to provide the optimum amount of stem cells that are needed to maintain the normal function. The goal of regenerative medicine is to amplify this natural repair system to keep pace with the demands of the patients. Orthopedics is one of the fields of regenerative medicine, which adopts natural healing process by stimulating regeneration of cells in the musculoskeletal system. Histogen Inc. is one of the manufacturer of orthopedic regenerative medicine and its product Human Extracellular matrix (hECM) is anti-inflammatory, angiogenic, and can stimulate growth of stem cells in damaged areas to induce tissue regeneration.

Restraints of the Global Regenerative Therapies Market

Lack of standardized guidelines on tissue and bio-medical engineering is expected to hinder growth of the global regenerative therapies market. Moreover, lengthy clinical trials leading to delayed entry of products in the market is expected to restrain growth of the market.

Key features of the study:

This report provides in-depth analysis of the global regenerative therapies market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players

It profiles leading players in the global regenerative therapies market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans

Key companies covered as a part of this study include Shire Pharmaceuticals, Kinetic Concepts, Inc., Mesoblast Ltd., Nuo Therapeutics (Cytomedix Inc.), Advanced Cell Technology, Inc., BioStem Life Sciences, Akron Biotechnology, LLC, Organovo Holdings Inc., Orgenesis Inc., Pluristem Therapeutics Inc., Genzyme, Athersys, Inc., RenovaCare, Inc., and Cytori Therapeutics, Inc.

Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics

The global regenerative therapies market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

Global Regenerative Therapies Market, By Tissue Type:

Allograft

Xenograft

Alloplast

Global Regenerative Therapies Market, By Application:

Soft Tissue Repair

Cardiovascular

Dental

Orthopedic

CNS disease treatment

Others

Global Regenerative Therapies Market, By End User:

Hospitals

Ambulatory Surgical Centers

Educational Institutes

Global Regenerative Therapies Market, By Geography:

North America

By Tissue Type

Allograft

Xenograft

Alloplast

By Application

Soft Tissue Repair

Cardiovascular

Dental

Orthopedic

CNS disease treatment

Others

By End User

Hospitals

Ambulatory Surgical Centers

Educational Institutes

By Country:

U.S.

Canada

Europe

By Tissue Type

Allograft

Xenograft

Alloplast

By Application

Soft Tissue Repair

Cardiovascular

Dental

Orthopedic

CNS disease treatment

Others

By End User

Hospitals

Ambulatory Surgical Centers

Educational Institutes

By Country:

U.K.

Germany

Italy

France

Spain

Russia

Rest of Europe

Asia Pacific

By Tissue Type

Allograft

Xenograft

Alloplast

By Application

Soft Tissue Repair

Cardiovascular

Dental

Orthopedic

CNS disease treatment

Others

By End User

Hospitals

Ambulatory Surgical Centers

Educational Institutes

By Country:

China

India

Japan

ASEAN

Australia

South Korea

Rest of Asia Pacific

Latin America

By Tissue Type

Allograft

Xenograft

Alloplast

By Application

Soft Tissue Repair

Cardiovascular

Dental

Orthopedic

CNS disease treatment

Others

By End User

Hospitals

Ambulatory Surgical Centers

Educational Institutes

By Country:

Brazil

Mexico

Argentina

Rest of Latin America

Middle East:

By Tissue Type

Allograft

Xenograft

Alloplast

By Application

Soft Tissue Repair

Cardiovascular

Dental

Orthopedic

CNS disease treatment

Others

By End User

Hospitals

Ambulatory Surgical Centers

Educational Institutes

By Country:

GCC

Israel

Rest of Middle East

Africa

By Tissue Type

Allograft

Xenograft

Alloplast

By Application

Soft Tissue Repair

Cardiovascular

Dental

Orthopedic

CNS disease treatment

Others

By End User

Hospitals

Ambulatory Surgical Centers

Educational Institutes

By Country/Region:

Central Africa

South Africa

North Africa

Company Profiles

Shire Pharmaceuticals *

Company Overview

Product Portfolio

Financial Performance

Key Strategies

Recent Developments

Kinetic Concepts, Inc.

Mesoblast Ltd.

Nuo Therapeutics (Cytomedix Inc.)

Advanced Cell Technology, Inc.

BioStem Life Sciences

Akron Biotechnology, LLC

Organovo Holdings Inc.

Orgenesis Inc.

Pluristem Therapeutics Inc.

Genzyme

Athersys, Inc.

RenovaCare, Inc.

Cytori Therapeutics, Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Product Code: CMI3712

Table of Contents

1. Research Objective and Assumption

    • Research Objectives
    • Assumptions
    • Abbreviations

2. Market Purview

    • Report Description
  • Market Definition and Scope
    • Executive Summary
  • Market Snippet, By Tissue Type
  • Market Snippet, By Application
  • Market Snippet, By End User
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Regulatory Scenario
    • PEST Analysis

4. Global Regenerative Therapies Market, By Tissue Type, 2017 - 2028 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
    • Allograft
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Segment Trends
    • Xenograft
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Segment Trends
    • Alloplast
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Segment Trends

5. Global Regenerative Therapies Market, By Application, 2017 - 2028 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
    • Soft Tissue Repair
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Cardiovascular
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Dental
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Orthopedic
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • CNS disease treatment
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

6. Global Regenerative Therapies Market, By End User, 2017 - 2028 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
    • Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Ambulatory Surgical Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Educational Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

7. Global Regenerative Therapies Market, By Regions, 2017 - 2028 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
    • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • U.S.
    • Canada
    • Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
    • Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

    • Company Profiles
  • Shire Pharmaceuticals
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Kinetic Concepts, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Mesoblast Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Nuo Therapeutics (Cytomedix Inc.)
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Advanced Cell Technology, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • BioStem Life Sciences
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Akron Biotechnology, LLC
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Organovo Holdings Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Orgenesis Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Pluristem Therapeutics Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Genzyme
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Athersys, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • RenovaCare, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cytori Therapeutics, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

9. Section

    • References
    • Research Methodology
    • About us and Sales Contact
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!